These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

166 related items for PubMed ID: 19996640

  • 1. Thrombophilia and transient risk factors for venous thromboembolism in women with distal deep vein thrombosis.
    Cozza S, Mercier G, Schved JF, Biron-Andréani C.
    Pathophysiol Haemost Thromb; 2008; 36(5):282-4. PubMed ID: 19996640
    [No Abstract] [Full Text] [Related]

  • 2. Hypercoagulability and hypofibrinolysis and risk of deep vein thrombosis and splanchnic vein thrombosis: similarities and differences.
    Smalberg JH, Kruip MJ, Janssen HL, Rijken DC, Leebeek FW, de Maat MP.
    Arterioscler Thromb Vasc Biol; 2011 Mar; 31(3):485-93. PubMed ID: 21325670
    [Abstract] [Full Text] [Related]

  • 3. Inherited thrombophilia and first venous thromboembolism during pregnancy and puerperium.
    Martinelli I, De Stefano V, Taioli E, Paciaroni K, Rossi E, Mannucci PM.
    Thromb Haemost; 2002 May; 87(5):791-5. PubMed ID: 12038778
    [Abstract] [Full Text] [Related]

  • 4. [Thrombophilia and the prevention of thromboembolic complications during pregnancy and the puerperium].
    Wouters MG, Nováková IR, Steegers EA.
    Ned Tijdschr Geneeskd; 2003 May 31; 147(22):1060-6. PubMed ID: 12814017
    [Abstract] [Full Text] [Related]

  • 5. Risk factors and recurrence rate of primary deep vein thrombosis of the upper extremities.
    Martinelli I, Battaglioli T, Bucciarelli P, Passamonti SM, Mannucci PM.
    Circulation; 2004 Aug 03; 110(5):566-70. PubMed ID: 15262837
    [Abstract] [Full Text] [Related]

  • 6. Inherited thrombophilic risk factors in a large cohort of individuals referred to Italian thrombophilia centers: distinct roles in different clinical settings.
    Margaglione M, Brancaccio V, Ciampa A, Papa ML, Grandone E, Di Minno G.
    Haematologica; 2001 Jun 03; 86(6):634-9. PubMed ID: 11418373
    [Abstract] [Full Text] [Related]

  • 7. Venous thromboembolism: risk factors for recurrence.
    Zhu T, Martinez I, Emmerich J.
    Arterioscler Thromb Vasc Biol; 2009 Mar 03; 29(3):298-310. PubMed ID: 19228602
    [Abstract] [Full Text] [Related]

  • 8. The utility of thrombophilia testing in pregnant women with thrombosis: fact or fiction?
    Scifres CM, Macones GA.
    Am J Obstet Gynecol; 2008 Oct 03; 199(4):344.e1-7. PubMed ID: 18572147
    [Abstract] [Full Text] [Related]

  • 9. Risk of venous thromboembolism after air travel: interaction with thrombophilia and oral contraceptives.
    Martinelli I, Taioli E, Battaglioli T, Podda GM, Passamonti SM, Pedotti P, Mannucci PM.
    Arch Intern Med; 2008 Oct 03; 163(22):2771-4. PubMed ID: 14662632
    [Abstract] [Full Text] [Related]

  • 10. Deep venous thrombosis of the upper extremity: is thrombophilia a relevant clinical issue?
    Hoffmann U, Spannagl M.
    Thromb Haemost; 2008 Sep 03; 100(3):369-70. PubMed ID: 18766248
    [No Abstract] [Full Text] [Related]

  • 11. Thrombophilic abnormalities and recurrence of venous thromboembolism in patients treated with standardized anticoagulant treatment.
    Santamaria MG, Agnelli G, Taliani MR, Prandoni P, Moia M, Bazzan M, Guazzaloca G, Ageno W, Bertoldi A, Silingardi M, Tomasi C, Ambrosio GB, Warfarin Optimal Duration Italian Trial (WODIT) Investigators.
    Thromb Res; 2005 Sep 03; 116(4):301-6. PubMed ID: 16038714
    [Abstract] [Full Text] [Related]

  • 12. Venous thromboembolism, fetal loss and preeclampsia in pregnant women with congenital thrombophilia.
    Prandoni P, Tormene D, Simioni P, Girolami A.
    Clin Lab; 2001 Sep 03; 47(3-4):155-9. PubMed ID: 11294579
    [No Abstract] [Full Text] [Related]

  • 13. Thromboembolism in women.
    Martinelli I.
    Semin Thromb Hemost; 2006 Oct 03; 32(7):709-15. PubMed ID: 17024598
    [Abstract] [Full Text] [Related]

  • 14. Absolute risk of venous and arterial thromboembolism in thrombophilic families is not increased by high thrombin-activatable fibrinolysis inhibitor (TAFI) levels.
    Folkeringa N, Coppens M, Veeger NJ, Bom VJ, Middeldorp S, Hamulyak K, Prins MH, Büller HR, van der Meer J.
    Thromb Haemost; 2008 Jul 03; 100(1):38-44. PubMed ID: 18612536
    [Abstract] [Full Text] [Related]

  • 15. Thrombophilia and gestational VTE.
    Simioni P.
    Thromb Res; 2009 Jul 03; 123 Suppl 2():S41-4. PubMed ID: 19217475
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Duration of anticoagulant treatment and recurrence of venous thromboembolism in patients with and without thrombophilic abnormalities.
    Taliani MR, Becattini C, Agnelli G, Prandoni P, Moia M, Bazzan M, Salvi R, Ageno W, Guazzaloca G, Imberti D, Silingardi M, Poggio R, Warfarin Optimal Duration Italian Trial (WODIT) Investigators.
    Thromb Haemost; 2009 Mar 03; 101(3):596-8. PubMed ID: 19277429
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.